NeuroOne Medical Technologies Corporation (NMTC)Healthcare | Medical Devices | Eden Prairie, United States | NasdaqCM
1.10 USD
+0.03
(2.326%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 1:59 a.m. EDT
The investment case for NeuroOne is currently broken by a severe deterioration in profitability and a precarious regulatory standing. Despite a recent FDA clearance for the OneRF system, the company remains deeply unprofitable with negative operating margins and a massive cash burn, evidenced by negative free cash flow and a trailing P/E that is effectively infinite due to losses. The balance sheet is fragile, with debt significantly outweighing equity, creating a high risk of dilution or distress financing. While the stock trades at a low multiple relative to sales, this reflects the market's skepticism about the company's ability to monetize its technology without further capital injections. The recent reverse stock split announcement is a classic distress signal, often employed by companies struggling to meet listing requirements due to falling share prices. Technically, the stock is trading well below its 50-day and 200-day averages, confirming a long-term downtrend. Although the analyst consensus is surprisingly bullish with a high price target, this appears disconnected from the harsh reality of the fundamentals and the overwhelming bearish positioning in the options market. Investors should view this as a speculative gamble on a turnaround rather than a sound investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.116973 |
| AutoARIMA | 0.191853 |
| MSTL | 0.731778 |
| AutoETS | 0.732682 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 0.12 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.322 |
| Excess Kurtosis | -1.06 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.654 |
| Revenue per Share | 1.472 |
| Market Cap | 10,016,340 |
| Forward P/E | -3.93 |
| Beta | 0.76 |
| Profit Margins | -59.71% |
| Website | https://nmtc1.com |
As of Oct. 10, 2026, 1:59 a.m. EDT: Speculators are overwhelmingly bearish, with significant open interest concentrated in out-of-the-money puts at strikes of 5.0 and 7.5, while call activity is negligible and confined to deep out-of-the-money strikes. Implied volatility is elevated for puts relative to calls, indicating a fear of further downside rather than an expectation of a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8009259 |
| Address1 | 7,599 Anagram Drive |
| All Time High | 180.0 |
| All Time Low | 0.962 |
| Ask | 1.38 |
| Ask Size | 3 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 236,710 |
| Average Daily Volume3 Month | 338,761 |
| Average Volume | 338,761 |
| Average Volume10Days | 236,710 |
| Beta | 0.761 |
| Bid | 1.36 |
| Bid Size | 3 |
| Book Value | 0.433 |
| City | Eden Prairie |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.1 |
| Current Ratio | 2.836 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.14 |
| Day Low | 1.0504 |
| Debt To Equity | 4.654 |
| Display Name | NeuroOne Medical |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,624,200 |
| Earnings Call Timestamp Start | 1,786,624,200 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda | -7,663,002 |
| Ebitda Margins | -0.61458 |
| Enterprise To Ebitda | -1.063 |
| Enterprise To Revenue | 0.653 |
| Enterprise Value | 8,144,088 |
| Eps Forward | -0.28 |
| Eps Trailing Twelve Months | -0.99 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.5509 |
| Fifty Day Average Change | -0.45089996 |
| Fifty Day Average Change Percent | -0.29073438 |
| Fifty Two Week Change Percent | -80.09259 |
| Fifty Two Week High | 6.12 |
| Fifty Two Week High Change | -5.02 |
| Fifty Two Week High Change Percent | -0.8202615 |
| Fifty Two Week Low | 0.962 |
| Fifty Two Week Low Change | 0.13800001 |
| Fifty Two Week Low Change Percent | 0.14345115 |
| Fifty Two Week Range | 0.962 - 6.12 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,521,120,600,000 |
| Float Shares | 6,262,853 |
| Forward Eps | -0.28 |
| Forward P E | -3.9285715 |
| Free Cashflow | -4,566,159 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | 0.024999976 |
| Fullday Change Percent | 2.3255792 |
| Fullday Price | 1.1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.23005 |
| Gross Profits | 2,868,413 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.25441998 |
| Held Percent Institutions | 0.22454001 |
| Implied Shares Outstanding | 9,105,763 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-05-26 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,759,190,400 |
| Last Split Date | 1,776,297,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota. |
| Long Name | NeuroOne Medical Technologies Corporation |
| Market | us_market |
| Market Cap | 10,016,340 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_412033082 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -7,445,464 |
| Next Fiscal Year End | 1,790,726,400 |
| Non Diluted Market Cap | 12,247,251 |
| Number Of Analyst Opinions | 3 |
| Open | 1.08 |
| Operating Cashflow | -7,052,007 |
| Operating Margins | -1.22868 |
| Phone | 952 426 1383 |
| Previous Close | 1.075 |
| Price Hint | 4 |
| Price To Book | 2.5404158 |
| Price To Sales Trailing12 Months | 0.8033177 |
| Profit Margins | -0.59713 |
| Quick Ratio | 1.541 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.025 |
| Regular Market Change Percent | 2.32558 |
| Regular Market Day High | 1.14 |
| Regular Market Day Low | 1.0504 |
| Regular Market Day Range | 1.0504 - 1.14 |
| Regular Market Open | 1.08 |
| Regular Market Previous Close | 1.075 |
| Regular Market Price | 1.1 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 108,327 |
| Return On Assets | -0.58068 |
| Return On Equity | -1.24662 |
| Revenue Growth | 0.163 |
| Revenue Per Share | 1.472 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 9,105,763 |
| Shares Percent Shares Out | 0.0196 |
| Shares Short | 178,730 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 242,435 |
| Short Name | NeuroOne Medical Technologies C |
| Short Percent Of Float | 0.020299999 |
| Short Ratio | 1.27 |
| Source Interval | 15 |
| State | MN |
| Symbol | NMTC |
| Target High Price | 8.8 |
| Target Low Price | 5.0 |
| Target Mean Price | 7.26667 |
| Target Median Price | 8.0 |
| Total Cash | 2,047,596 |
| Total Cash Per Share | 0.225 |
| Total Debt | 175,345 |
| Total Revenue | 12,468,715 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.99 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.48703 |
| Two Hundred Day Average Change | -2.3870301 |
| Two Hundred Day Average Change Percent | -0.68454534 |
| Type Disp | Equity |
| Volume | 108,327 |
| Website | https://nmtc1.com |
| Zip | 55,344 |